My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 103

2.

A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.

Naslund MJ, Miner M.

Clin Ther. 2007 Jan;29(1):17-25. Review.PMID: 17379044 [PubMed - indexed for MEDLINE]Related articles

3.

STEP: Simplified Treatment of the Enlarged Prostate.

Rosenberg MT, Miner MM, Riley PA, Staskin DR.

Int J Clin Pract. 2009 Dec 22. [Epub ahead of print]PMID: 20039975 [PubMed - as supplied by publisher]Related articles

4.

5alpha-reductase inhibition for men with enlarged prostate.

Issa MM, Kraft KH.

J Am Acad Nurse Pract. 2007 Aug;19(8):398-407. Review.PMID: 17655569 [PubMed - indexed for MEDLINE]Related articles

5.

Finasteride in the treatment of patients with benign prostatic hyperplasia: a review.

Smith AB, Carson CC.

Ther Clin Risk Manag. 2009 Jun;5(3):535-45. Epub 2009 Jul 12.PMID: 19707263 [PubMed - in process]Related articlesFree article

6.

Progression, risk factors and subsequent medical management of symptomatic benign prostatic hyperplasia.

Pinto F, Racioppi M, Sacco E, Totaro A, Brescia A, Volpe A, Gardi M, Bassi PF.

Arch Ital Urol Androl. 2009 Mar;81(1):1-8. Review.PMID: 19499750 [PubMed - indexed for MEDLINE]Related articles

7.

Dutasteride: a review of its use in the management of prostate disorders.

Keam SJ, Scott LJ.

Drugs. 2008;68(4):463-85. Review.PMID: 18318566 [PubMed - indexed for MEDLINE]Related articles

8.

BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.

Roehrborn CG.

BJU Int. 2008 Mar;101 Suppl 3:17-21. Review.PMID: 18307681 [PubMed - indexed for MEDLINE]Related articles

9.

Current status of 5alpha-reductase inhibitors in the treatment of benign hyperplasia of prostate.

Kumar VL, Wahane VD.

Indian J Med Sci. 2008 Apr;62(4):167-75. Review.PMID: 18445985 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.

Naslund M, Eaddy MT, Hogue SL, Kruep EJ, Shah MB.

Curr Med Res Opin. 2009 Nov;25(11):2663-9.PMID: 19757985 [PubMed - indexed for MEDLINE]Related articles

11.

Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design.

Siami P, Roehrborn CG, Barkin J, Damiao R, Wyczolkowski M, Duggan A, Major-Walker K, Morrill BB; CombAT study group.

Contemp Clin Trials. 2007 Nov;28(6):770-9. Epub 2007 Aug 2.PMID: 17761460 [PubMed - indexed for MEDLINE]Related articles

12.

Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management.

Emberton M, Cornel EB, Bassi PF, Fourcade RO, Gómez JM, Castro R.

Int J Clin Pract. 2008 Jul;62(7):1076-86. Epub 2008 May 8. Review.PMID: 18479366 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.

Dedhia RC, Calhoun E, McVary KT.

J Urol. 2008 Jan;179(1):220-5. Epub 2007 Nov 14.PMID: 18001791 [PubMed - indexed for MEDLINE]Related articles

14.

5-Alpha reductase inhibitors in men with an enlarged prostate: an evaluation of outcomes and therapeutic alternatives.

Naslund M, Regan TS, Ong C, Hogue SL.

Am J Manag Care. 2008 May;14(5 Suppl 2):S148-53.PMID: 18611088 [PubMed - indexed for MEDLINE]Related articlesFree article

15.

Update on the use of dutasteride in the management of benign prostatic hypertrophy.

Miller J, Tarter TH.

Clin Interv Aging. 2007;2(1):99-104. Review.PMID: 18044081 [PubMed - indexed for MEDLINE]Related articlesFree article

16.

The role of combination medical therapy in benign prostatic hyperplasia.

Greco KA, McVary KT.

Int J Impot Res. 2008 Dec;20 Suppl 3:S33-43. Review.PMID: 19002123 [PubMed - indexed for MEDLINE]Related articles

17.

Chronic prostatitis: management strategies.

Murphy AB, Macejko A, Taylor A, Nadler RB.

Drugs. 2009;69(1):71-84. doi: 10.2165/00003495-200969010-00005. Review.PMID: 19192937 [PubMed - indexed for MEDLINE]Related articles

18.

Diagnosis and management of benign prostatic hyperplasia.

Edwards JL.

Am Fam Physician. 2008 May 15;77(10):1403-10. Review.PMID: 18533373 [PubMed - indexed for MEDLINE]Related articlesFree article

19.

Acute urinary retention: medical management and the identification of risk factors for prevention.

Khastgir J, Khan A, Speakman M.

Nat Clin Pract Urol. 2007 Aug;4(8):422-31. Review.PMID: 17673913 [PubMed - indexed for MEDLINE]Related articles

20.

Medical management of benign prostatic hypertrophy.

Nix JW, Carson CC.

Can J Urol. 2007 Dec;14 Suppl 1:53-7. Review.PMID: 18163946 [PubMed - indexed for MEDLINE]Related articles

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Write to the Help Desk